ADARx (ADRX) news
Recent news
Spruce announces separation of CRHX-101 program into Adrenyx
AInvest Wire · Nov 9, 2026Adarx Pharmaceuticals, Inc.: Morgan Stanley initiates coverage with overweight rating; target price $32
AInvest Wire · Oct 21, 2026Adarx Pharmaceuticals, Inc.: UBS initiates coverage with buy rating; target price $35
AInvest Wire · Oct 21, 2026Adherium Ltd - Appointed Brad Wilson as CFO
Adherium Limited (ASX: ADR) has announced the appointment of Brad Wilson as its new Chief Financial Officer, effective immediately. Wilson brings extensive financial leadership experience across the healthcare and technology sectors, having previously held senior roles at several publicly traded…
AInvest Wire · Oct 11, 2026HBM Healthcare Investments posts solid half-year result – expected profit of CHF 177 million
HBM Healthcare Investments AG has reported a strong half-year performance, with an expected profit of CHF 177 million for the period. This result reflects continued growth and successful investment strategies across its portfolio companies. The firm has recently made significant investments in…
AInvest Wire · Oct 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

